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Introduction
Some anaerobic infections (e.g., tetanus and gas gan-
grene) are transmitted via environmental factors (soil,
etc.), but common types of anaerobic infections occur in
the form of endogenous infections caused by indigenous
bacterial ﬂora. Search for anaerobes requires special
media and culture environments and takes about 1 week.
Although attempts have recently made to develop more
rapid anaerobe testing systems facilitating early treatment
of anaerobic infections [1], the delay in obtaining culture
test results remains an essentially unresolved problem.
Gram staining of specimens from patients can yield rapid
results, which can be utilized for the diagnosis and
treatment of anaerobic infections. However, culture and
drug sensitivity test results are obtained much later
(mostly after treatment has been started). Thus, the
diagnosis and treatment of anaerobic infections still rely
heavily on knowledge and experience. This chapter will
ﬁrst brieﬂy characterize infections likely to involve
indigenous bacterial ﬂora and anaerobes, as basic
knowledge indispensable for understanding anaerobic
infections. Then, accounts will be given as to the
frequency of anaerobe isolation and the sensitivities of
isolated anaerobes to antimicrobial agents, primarily
based on laboratory data. Because collected data can vary
depending on the testing methods and manipulations,
media used, duration of observation, methods adopted for
identiﬁcation, data processing methods, and so on,
subsequent discussions will be based on data collected at
a single laboratory (Clinical Laboratory of Juntendo
University Hospital) to avoid biases stemming from these
factors.
Major anaerobes and their sites of colonization
Although most anaerobic infections are caused by indige-
nous bacteria of the host, the number of frequently detected
species as pathogens in anaerobic infections is relatively
small [2–5]. Table 1 shows the major anaerobic indigenous
bacteria seen in humans. Anaerobes occurring in the highest
numbers are Porphyromonas, Prevotella, Fusobacterium
(F. nucleatum, etc.), gram-positive cocci such as Pepto-
streptococcus, and Actinomyces, in the oral cavity and upper
airway. These bacteria are frequently isolated as pathogens
infecting organs above the diaphragm (brain, spinal cord,
neck and lungs). Bacteroides fragilis (B. fragilis) group and
Clostridium species constitute a representative bacteria in the
large bowel and are isolated from patients with abdominal,
gastrointestinal or genital tract infections. Prevotella bivia is
often isolated, together with the B. fragilis group, from
patients with gynecological infections. Propionibacterium
acnes is a representative indigenous bacteriumof the skin and
is responsible for acne and endophthalmitis after cataract
surgery. Finegoldia magna is likely to be misidentiﬁed as
Staphylococcus spp. when gram stained; it is often isolated
from gynecological materials and specimens from skin and
soft tissue infections. Adequate knowledge of the common
sites of colonization by anaerobes is useful for determining
pathogens and estimating their routes of invasion.
Infections often involving anaerobes and infections
unlikely to involve anaerobes
There is a report concerning the attempt to classify infec-
tions according to the degree of anaerobe involvement
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rated on a four-category scale: (1) very high (frequency of
anaerobe isolation C70–100%), (2) high (50–100%), (3)
low (9–40%) and (4) very rare (B1%). The information
shown below, described in this report, may be useful in the
diagnosis and treatment of infections [6].
1. Very high (frequency of anaerobe isolationC70–100%):
gas gangrene, pilonidal cyst, diabetic gangrene/foot
ulcers, post-appendectomy infections, infections after
colorectal surgery, perianal abscess, lung abscess,
nonclostridial crepitant cellulites
2. High (50–100%): aspiration pneumonia/lung abscess,
brain abscess, intraperitoneal/pelvic abscess, soft tis-
sue/subcutaneous abscess, dental/oral infections,
chronic sinusitis, mammary abscess
3. Low (9–40%): osteomyelitis, bacteremia
4. Very rare (B1%): urinary tract infections
Epidemiological information on anaerobes
derived from laboratory test data
Annual changes in the frequency of anaerobe isolation
Annual changes in the frequency of anaerobe isolation
(during 1994–2003) from clinical materials are shown in
Fig. 1 (anaerobes isolated from outpatients) and Fig. 2
(anaerobes isolated from inpatients). Before 1997, anaer-
obes accounted for 15% or more of all bacteria isolated
from outpatients. After 1997, this percentage tended to
decrease, reaching about 13% in 2003. The percentage of
anaerobes among the bacteria isolated from inpatients has
remained at 7–8%, lower than the percentage for
outpatients, and there have been no large annual changes in
this percentage. The higher percentage of anaerobes isolated
from outpatients than inpatients appears to be attributable to
the higher number of specimens collected after chemo-
therapy in the inpatient group than that in the outpatient
group. The percentage of anaerobes among all bacteria
isolated from outpatients tended to decrease slightly after
2000. This change may be associated with the diminished
scale of anaerobe testing aimed at facilitating rapid report-
ing of test results and minimizing the labor involved in
testing. In view of this possibility, data from blood culture
tests, involving no such artiﬁcial manipulation, are sum-
marized in Fig. 3 [7]. The bar graph in this ﬁgure shows the
total number of bacteria isolated by blood culture, and the
Table 1 Major anaerobic
indigenous bacteria found in
humans
Site Bacteria
Oral cavity, upper airway Genus Prevotella (pigment-forming bacteria), Genus Porphyromonas, Genus
Prevotella (non-pigment-forming bacteria, especially P. oralis), Genus
Bacteroides (B. ureolyticus, etc.), Genus Fusobacterium (especially
F. nucleatum), Genus Peptostreptococcus (Anaerobic streptococcus),
Genus Veillonella, Genus Actinomyces, Genus Propionibacterium
Stomach (during hunger) Genus Lactobacillus
Small intestine (close to
center)
Anaerobic streptococcus, Lactobacillus spp.
Colon Bacteroides fragilis group, Porphyromonas spp., Fusobacterium spp.,
Anaerobic cocci (numerous bacteria), Clostridium spp., Eubacterium spp.,
Biﬁdobacterium spp., Propionibacterium spp.
Genital organs, vagina,
cervix
Prevotella (pigment-forming bacteria), Porphyromonas spp., Prevotella spp.
(non-pigment-forming bacteria), Bacteroides spp., Peptostreptococcus spp.,
Clostridium spp., Veillonella spp., Lactobacillus spp., Eubacterium spp.,
Propionibacterium spp.
Urethra (male and female) Propionibacterium spp., Peptostreptococcus spp., Bacteroides spp.
(Prevotella), Fusobacterium spp.
Skin Propionibacterium spp., Peptostreptococcus spp.
1994 (3,900)
1995 (4,576)
1996 (5,488)
1997 (6,034)
1998 (5,692)
1999 (5,453)
2000 (5,588)
2001 (6,030)
2002 (6,273)
2003 (7,613)
Total (56,647)
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(%)
Gram-positive cocci
Gram-positive rods
Gram-negative rods
Gram-negative cocci
Enterobacteria
Non-fermenting bacteria
Anaerobic bacteria
Fungi
Fig. 1 Frequency of isolation of bacteria from clinical materials
(outpatients)
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line graph indicates the frequency of anaerobe isolation.
Between 1961 and 1964, the percentage of anaerobes was as
high as 28.1%, but decreased sharply thereafter, reaching
5–6% during the 1979–1988 period and remaining at about
10% during the 1989–2002 period. Then, the percentage
dropped to only 3.8% during the 2003–2004 period. The
latest sharp decrease appears to be attributable to switching
of the conventional BCB System [Becton, Dickinson and
Company Japan (F. Hoffmann-La Roche and Co. Ltd.,
Switzerland)] to the BACTEC System (Becton, Dickinson
and Company Japan) in July 2004 for use in blood cultures.
One observation supporting this view is that the number of
aerobes isolated increased after the BACTEC System was
introduced, suggesting that isolation of anaerobes probably
decreased. Another piece of evidence for this view is that
anaerobes belonging to genus Propionibacterium have been
isolated less frequently with the BACTEC System despite
having been isolated quite frequently with the BCB System.
With the BCB System, culture and observation continue for
7–8 days, and gram staining and aerobic and anaerobic sub-
culturing of the cultured sample are performed as ﬁnal
checks. With the BACTEC System, on the other hand,
culture and observation continue for 5 days, and gram
staining and subculture are skipped. This difference between
the old and new systems may be responsible for the recent
decrease in anaerobe isolation. Assuming that isolation of
Propionibacterium decreased following introduction of the
BACTEC System, the decrease may be attributable to the
following factors: (1) difference in medium composition, (2)
automated detector features, (3) shortened culture period,
and so on. It is not known which of these factors, or com-
binations of factors, is actually responsible for the decrease.
In any event, follow-up data in forthcoming years is
essential.
Regarding annual changes in anaerobes, the report by
Hiramatsu et al. [8] pointed out a marked tendency for a
decrease after 1995, and the report by Adachi et al. [9] also
demonstrated a trend toward a decrease. In recent years, the
scale of anaerobe testing has tended to diminish. In addi-
tion to this factor for laboratory procedure, it is noteworthy
that the prevalence of anaerobic infection has been
decreasing since the introduction of broad-spectrum anti-
microbial agents such as carbapenems.
Frequency of anaerobe isolation for each category
of test specimens
Figures 4 and 5 show the frequency of anaerobe isolation
for each category of specimens when anaerobic cultures
were conducted [10]. Many of the respiratory specimens
found to be anaerobe positive contained pus from patients
with peritonsillar abscesses, sputum from patients with
aspiration pneumonia, etc. Many of the anaerobes isolated
from urogenital organs were associated with infection of
female genital organs and their appendages. The frequency
1994 (12,355)
1995 (13,459)
1996 (13,344)
1997 (15,197)
1998 (13,940)
1999 (14,149)
2000 (12,931)
2001 (12,894)
2002 (13,188)
2003 (14,675)
Total (136,132)
Gram-positive cocci
Gram-positive rods
Gram-negative rods
Gram-negative cocci
Enterobacteria
Non-fermenting bacteria
Anaerobic bacteria
Fungi
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Fig. 2 Frequency of isolation of bacteria from clinical materials
(inpatients)
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of anaerobe isolation from respiratory and urogenital
specimens was high for outpatients, suggesting that
anaerobes are often involved in the primary infection.
Anaerobes are rarely isolated in community-acquired
pneumonia [11]. The frequency of anaerobe isolation is
very high for patients hospitalized with gastrointestinal
disease. This is because these inpatients often receive a
check for Clostridium difﬁcile (C. difﬁcile). Figure 5 shows
details of isolation frequency in pus, secretions and punc-
ture ﬂuids. The frequency of anaerobe isolation was high
(over 30%) from ascites, ﬂuids collected by Douglas pouch
puncture, ﬁstulae and abscesses [10]. The frequency was
also high (over 20%) from ﬂuid collected by maxillary
sinus puncture, pleural effusion, other puncture ﬂuid and
drain ﬂuid. Meanwhile, the frequence was low from
synovial ﬂuids, ocular discharge, otorrhea and catheters.
Anaerobes are known to often be isolated from closed pus.
This is closely related to the previously described ‘‘infec-
tion involving anaerobes’’. It can reasonably be said that
anaerobes are often involved in infections of the intra-
peritoneal cavity, thoracic cavity, female genital organs,
skin/soft tissues, nerve tissues (brain, epidural tissue and
subdural tissue), oral cavity and neck.
Frequency of isolation of anaerobes from clinical
materials
Figure 6 shows frequency of anaerobes isolated from
clinical materials. Of all those isolated, gram-positive and
gram-negative anaerobes each accounted for about half.
Gram-positive cocci and Prevotella were isolated most
frequently (each 22–23%) [10]. Clostridium accounted for
14.1%, most of which was C. difﬁcile isolated from feces of
inpatients. Because Prevotella and Porphyromonas take a
long time to grow, these anaerobes are seldom detected if
anaerobic culture is not continued for more than 48 h.
Prevotella and Porphyromonas resemble each other in
terms of colony appearance and other morphological
features. Many of the anaerobes of these genera are easily
detected on anaerobic blood-agar since they form black to
brown colonies. However, 4–6 days of observation are
needed for their detection. These anaerobes are also
occasionally detected in blood culture. Isolation of
Porphyromonas is relatively rare. The frequencies of
Prevotella and Porphyromonas isolation sometimes differ
considerably among laboratories. This variability is often
attributable to differences in laboratory procedures
(particularly the medium used and the duration of culture).
Prevotella and the B. fragilis group are often isolated from
patients with infections of the abdomen and female genital
organs.
Frequency of isolation of anaerobes analyzed
by clinical materials
Figure 7 shows distribution of anaerobes in the clinical
materials tested. Gram-positive rods were often isolated
from blood, cerebrospinal ﬂuid (CSF) and vascular cathe-
ters, and most of them were belonged to Propionibacterium
species. Since these anaerobes are known to be represen-
tative bacteria constituting indigenous ﬂora of the skin,
their detection appears to reﬂect contamination at the
sampling site. Other than these bacteria, Bacteroides
(particularly the B. fragilis group) was often isolated from
blood. From respiratory organs, Prevotella was often iso-
lated, the B. fragilis group rarely. C. difﬁcile was an
overwhelmingly predominant anaerobe isolated from gas-
trointestinal materials. From urogenital materials, includ-
ing gynecologic materials, Prevotella was isolated most
frequently, and other gram-positive cocci belonging to
Peptostreptococcus, etc. were also frequently isolated.
Prevotella bivia was often isolated as the pathogen causing
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female genital tract infections. Bacteroides was often iso-
lated from pus, secretions, puncture ﬂuids and dialysis
ﬂuids. Many of the anaerobes of this genus belonged to the
B. fragilis group.
The B. fragilis group is representative of anaerobic
gram-negative rods. It is often isolated from patients with
infections of the abdomen and soft tissue. Figure 8 shows
details of isolation frequency among B. fragilis group.
B. fragilis accounted for the largest portion (about 40%),
followed by B. thetaiotaomicron. B. vulgatus, B. distasonis,
B. ovatus, and so on, were isolated as well. B. fragilis group
is known to be b-lactamase-producing organisms. They are
resistant to ampicillin (ABPC), cefazolin (CEZ), cefotiam
(CTM), ceftazidime (CAZ), cefotaxime (CTX), cefpirome
(CPR), etc., and are clinically important bacteria. This
group of bacteria is easy to culture and grows rapidly.
However, their features are quite similar among these
bacteria, and sometimes it makes difﬁcult to distinguish
the species. Isolation of metallo-b-lactamase-producing
bacteria is rare at present, but the clinically isolated bac-
teria of this type often belong to the B. fragilis.
Figure 9 summarizes the clinical backgrounds of patients
whose blood samples were found to contain anaerobes. Of
101 patients, 77.2% had malignant tumors, and 46.5% had
diseases of the hepatobiliary system. These ﬁndings indicate
special attention to anaerobic infections is required when
patients have cancer and/or hepatobiliary system disorders.
Susceptibility of anaerobes to antibacterial agents
Gram-positive cocci
Table 2 shows the drug susceptibility rate of anaerobic
gram-positive cocci. Streptococcus milleri is a group of
microaerophilic bacteria but is listed in this table because it
is frequently isolated from anaerobic cultures. In this table,
the susceptibility rate means the percentages of strains with
MIC under the category of susceptible (S) according to the
MIC breakpoint proposed by NCCLS (currently called the
Clinical and Laboratory Standards Institutes; CLSI) [12].
For those antibacterial agents for which CLSI breakpoints
are not available, susceptibility was determined by referring
to the breakpoints for analogous agents. Resistance to pen-
icillin was noted in some strains of Peptostreptococcus
anaerobicus but was not seen in the other gram-positive
cocci [13]. No strains showed resistant to cephems, carba-
penems or vancomycin (VCM). The percentage of erythro-
mycin (EM)-resistant strains was high among gram-positive
cocci. The percentage of clindamycin (CLDM)-resistant
strains was 10% or higher, although it was not as high as the
percentage of EM-resistant strains. On the whole, it is sug-
gested that drug resistant strains was low among gram-
positive cocci, except for strains resistant to macrolides
(MLs) or CLDM.
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Gram-positive rods
Table 3 shows the susceptibility rate of gram-positive rods.
Gardnerella vaginalis (a bacterium known to grow when
incubated in a CO2 rich atmosphere) was added to this
table since it is known to be responsible, like bacteria of
Mobiluncus species, for bacterial vaginosis. Eggerthella
lenta, previously known as Eubacterium lentum, is often
resistant to penicillins (PCs) and cephems, but it is highly
sensitive to MLs and CLDM. C. difﬁcile is also resistant to
many antimicrobial agents other than VCM. Propionib-
acetrium, Atopobium and G. vaginalis are highly sensitive
to many antibacterial agents. The susceptibility pattern of
C. difﬁcile does not differ markedly among different
strains, and no strain of this species showed resistant to
VCM [14]. Among anaerobic gram-positive rods, E. lenta
tends to be resistant to b-lactams (BLs), but this species is
not frequently isolated from clinical materials, and no case
of intractable infection by this bacterium has been
encountered at our facility.
Gram-negative rods
Table 4 shows the susceptibility rate of the B. fragilis
group and Table 5 shows that of the other gram-negative
rods to antimicrobial agents. Susceptibility of the B. fra-
gilis group is divided into three subgroups (B. fragilis,
B. thetaiotaomicron and other bacteria). The B. fragilis
group was often resistant to penicillins and many other
cephems, while it was highly sensitive to sulbactam/cef-
operazone (SBT/CPZ) and carbapenems. Although the
emergence of imipenem (IPM)-resistant strains of the B.
fragilis group has been attracting close attention, these
strains seem to be rare in Japan at present [2, 15, 16]. An
increase in strains of the B. fragilis group resistant to cef-
metazole (CMZ) and CLDM (drugs which have been used
in the treatment of B. fragilis group infections for many
years) has recently been reported. When using these drugs
for the treatment of B. fragilis group infections, it is
essential to conduct a drug sensitivity test and check that the
strains in a given case are not resistant to the drugs [17]. The
percentage of resistant strains was lower for Prevotella,
Porphyromonas and Fusobacterium than for the B. fragilis
group. Prevotella bivia, a b-lactamase-producing bacte-
rium, was often resistant to penicillins and cephems [18].
Conclusion
Recent trends in the isolation of anaerobes and their sus-
ceptibilities to drugs have been described above, primarily
based on bacteriological testing data. Isolation of anaerobes
from clinical materials is apparently decreasing slightly.T
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Table 3 Drug susceptibility rate of gram-positive rods
Bacterium No. of
strains
Benzylpenicillin
(penicillin G)
Ampicillin Piperacillin Cefazolin Cefmetazole Cefotiam Flomoxef Imipenem Meropenem Minocycline Erythromycin Clindamycin Vancomycin
20.5 20.5 232 216 216 216 216 24 24 24 20.5 22 22
E. lenta 8 12.5 37.5 100 12.5 87.5 0 25 100 100 87.5 100 100 ND
C. difﬁcile 247 ND 65.6 100 4 67.1 0 92.6 44.9 ND 95.9 6.9 14.6 100
Propionibacterium
ssp.
80 100 100 100 100 100 100 100 100 100 100 100 100 100
Mobiluncus ssp. 11 100 100 100 100 100 100 100 100 100 100 100 100 ND
G. vaginalis 208 100 100 100 100 100 100 100 100 100 100 100 100 100
* The numerals below the drug names indicate the MIC breakpoint (lg/mL). CLSI breakpoints are not available for cefazolin, cefotiam, ﬂomoxef, minocycline, erythromycin and vancomycin. Sensitivities
to these ﬁve drugs were rated on the basis of breakpoints for analogous drugs, if any, or breakpoints available for aerobes
Table 4 Drug susceptibility rates of Bacteroides fragilis group bacteria
Bacterium No. of
strains
Ampicillin Sulbactam/
ampicillin
Piperacillin Cefazolin Cefmetazole Cefotiam Flomoxef Imipenem Meropenem Minocycline Erythromycin Clindamycin
20.5 28/4 232 216 216 216 216 24 24 24 20.5 22
B. fragilis 167 0 95.2 76.6 0 76.8 0 76 98.8 98.8 88.5 4.8 37.1
B. thitaiotaomicron 82 0 92.4 43.9 0 11.5 0 43.8 96.4 96.4 100 2.1 3.7
Other Bacteroides 88 10.2 100 60.2 10.2 82.4 8 69.3 97.7 100 100 15.6 29.5
* The numerals below the drug names indicate the MIC breakpoint (lg/mL). CLSI breakpoints are not available for cefazolin, cefotiam, ﬂomoxef, minocycline and erythromycin. Sensitivities to these ﬁve
drugs were rated on the basis of breakpoints for analogous drugs, if any, or breakpoints available for aerobes
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However, anaerobes are often involved in infections such
as peritonsillar abscesses and both intraperitoneal and
uterine appendage infections, and they still play an
important role in these infections. Most anaerobic infec-
tions are detected in the form of mixed anaerobe-aerobe
infections. It is therefore essential to precisely identify
the pathogen(s) among the isolated bacteria in individual
cases.
The patterns of susceptibility to antimicrobial agent vary
among different genera or types of anaerobes, and different
from the patterns known for aerobes. These differences
must be taken into account. The B. fragilis group has
shown the most marked development of drug resistance. At
present, the percentage of anaerobe strains resistant to
carbapenems is low but the percentage of strains resistant
to CLDM is quite high. It is therefore desirable to perform
a drug susceptibility test and check that the strains in a
given case are not resistant to the drugs.
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